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Background
ATP-dependent nucleosome remodelers influence
genetic processes by altering nucleosome occupancy,
positioning, and composition. In vitro, yeast imitation
switch (ISWI) and chromodomain helicase DNA-binding
(CHD) remodelers bind ~30-85 bp of extranucleosomal
DNA [1-3]. However, in vivo, ISWI and CHD remodelers
act within gene bodies [4], which contain regularly
spaced nucleosomes separated by less than 20 bp of lin-
ker DNA [5]. How, then, do ISWI and CHD remodelers
act within regions containing insufficient linker DNA for
their association with chromatin?
Methods
To resolve this apparent paradox, we have mapped the
genomic distributions of the yeast Isw1, Isw2, and Chd1
remodelers at base-pair resolution using immunoprecipita-
tion of MNase-digested native chromatin and high-
throughput sequencing (N-ChIP-seq).
Results
We find that ISWI and CHD remodelers are most highly
enriched at nucleosome-depleted regions (NDRs), where
they bind to regions of extended linker DNA adjacent to
particular transcription factors. Surprisingly, remodeler-
NDR association is independent of catalytic activity, sug-
gesting that remodeler binding to NDRs is not catalytically
relevant but instead poises remodelers for action within
gene bodies. Remodeler occupancy is correlated with
nucleosome turnover, suggesting that remodelers act
within regions of transient nucleosome depletion following
transcriptional elongation.
Conclusions
We suggest that transcription factors recruit ISWI and
CHD remodelers to their binding sites within NDRs,
where there is ample linker DNA to facilitate their associa-
tion with chromatin. Transcriptional elongation then
evicts or disrupts nucleosomes, creating regions of
extended linker DNA within gene bodies. NDR-bound
ISWI and CHD remodelers would thus be poised to follow
in the wake of RNA polymerase II, efficiently repositioning
nucleosomes within regions of extended linker DNA. This
model reconciles the seemingly incompatible in vitro
extranucleosomal DNA requirements of ISWI and CHD
remodelers with the short linkers found in vivo.
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